These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35885812)

  • 1. Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?
    Adepoju VA; Oladimeji O; Horsburgh CR
    Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic assessment of the concept and practice of public-private mix for tuberculosis care and control.
    Malmborg R; Mann G; Squire SB
    Int J Equity Health; 2011 Nov; 10():49. PubMed ID: 22074377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public-Private Mix Models of Tuberculosis Care in Pakistan: A High-Burden Country Perspective.
    Ullah W; Wali A; Haq MU; Yaqoob A; Fatima R; Khan GM
    Front Public Health; 2021; 9():703631. PubMed ID: 34447737
    [No Abstract]   [Full Text] [Related]  

  • 5. Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Uplekar M
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1424-1429. PubMed ID: 27776581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of tuberculosis care in the private health sector.
    Stallworthy G; Dias HM; Pai M
    J Clin Tuberc Other Mycobact Dis; 2020 Aug; 20():100171. PubMed ID: 32642560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.
    Sidharta SD; Yin JD; Yoong JS; Khan MS
    BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review on public private mix TB control strategy in India.
    Menberu M; Kar S; Ranjan Behera M
    Indian J Tuberc; 2022 Jul; 69(3):277-281. PubMed ID: 35760477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.
    Nwe TT; Saw S; Le Win L; Mon MM; van Griensven J; Zhou S; Chinnakali P; Shah S; Thein S; Aung ST
    Infect Dis Poverty; 2017 Sep; 6(1):123. PubMed ID: 28859677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engaging the Private Health Service Delivery Sector for TB Care in India-Miles to Go!
    Suseela RP; Shannawaz M
    Trop Med Infect Dis; 2023 May; 8(5):. PubMed ID: 37235313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involving private health care providers in delivery of TB care: global strategy.
    Uplekar M
    Tuberculosis (Edinb); 2003; 83(1-3):156-64. PubMed ID: 12758206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.
    Shibu V; Daksha S; Rishabh C; Sunil K; Devesh G; Lal S; Jyoti S; Kiran R; Bhavin V; Amit K; Radha T; Sandeep B; Minnie K; Kaur GR; Vaishnavi J; Sudip M; Sameer K; Achutan NS; Sanjeev K; Puneet D
    Indian J Tuberc; 2020 Apr; 67(2):189-201. PubMed ID: 32553311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size and usage patterns of private TB drug markets in the high burden countries.
    Wells WA; Ge CF; Patel N; Oh T; Gardiner E; Kimerling ME
    PLoS One; 2011 May; 6(5):e18964. PubMed ID: 21573227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood TB in Myanmar: trends in notification, profile and treatment outcomes in the private sector.
    Thein SK; Satyanarayana S; Kyaw KWY; Saw S; Maung TN; Swe PP; Thu MK; Aung ST
    Public Health Action; 2019 Dec; 9(4):135-141. PubMed ID: 32042604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public-private mix for tuberculosis care and control: a systematic review.
    Lei X; Liu Q; Escobar E; Philogene J; Zhu H; Wang Y; Tang S
    Int J Infect Dis; 2015 May; 34():20-32. PubMed ID: 25722284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries.
    Klinton JS; Heitkamp P; Rashid A; Faleye BO; Win Htat H; Hussain H; Syed I; Farough K; Mortera L; Moh Lwin M; Jha N; Ananthakrishnan R; Mahfuza R; Chadha SS; Banu S; Mannan S; Vijayan S; Ahmed S; Ali T; Oga-Omenka C; Kaur M; Singh U; Wells WA; Stallworthy G; Dias HMY; Pai M
    J Clin Tuberc Other Mycobact Dis; 2021 Dec; 25():100277. PubMed ID: 34545343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis patients not covered by treatment in public health services: findings from India's National Family Health Survey 2015-16.
    Pardeshi G; Deluca A; Agarwal S; Kishore J
    Trop Med Int Health; 2018 Aug; 23(8):886-895. PubMed ID: 29851437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Global Fund's investments to expand innovative public-private provider engagement in TB.
    Yassin MA; Kimbo L; Wandwalo E; Rashid A; Dzokoto A; Weber U; Stallworthy G
    IJTLD Open; 2024 Jun; 1(6):250-257. PubMed ID: 39021451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India.
    Floyd K; Arora VK; Murthy KJ; Lonnroth K; Singla N; Akbar Y; Zignol M; Uplekar M
    Bull World Health Organ; 2006 Jun; 84(6):437-45. PubMed ID: 16799727
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.